HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.

Abstract
There is increasing evidence that bone marrow stromal cells (BMSC) have the potential to migrate into the injured neural tissue and to differentiate into the CNS cells, indicating the possibility of autograft transplantation therapy. The present study was aimed to clarify whether the mouse BMSC can migrate into the lesion and differentiate into the CNS cells when transplanted into the mice subjected to focal cerebral infarct or spinal cord injury. The BMSC were harvested from mice and characterized by flow cytometry. Then, the BMSC were labeled by bis-benzimide, a nuclear fluorescence dye, over 24 h, and were stereotactically transplanted into the brain or spinal cord of the mice. The cultured BMSC expressed low levels of CD45 and high levels of CD90 and Sca-1 on flow cytometry. A large number of grafted cells survived in the normal brain 4 weeks after transplantation, many of which were located close to the transplanted sites. They expressed the neuronal marker including NeuN, MAP2, and doublecortin on fluorescent immunohistochemistry. However, when the BMSC were transplanted into the ipsilateral striatum of the mice subjected to middle cerebral artery occlusion, many of the grafted cells migrated into the corpus callosum and injured cortex, and also expressed the neuronal markers 4 weeks after transplantation. In particular, NeuN was very useful to validate the differentiation of the grafted cells, because the marker was expressed in the nuclei and was overlapped with bis-benzimide. Similar results were obtained in the mice subjected to spinal cord injury. However, many of the transplanted BMSC expressed GFAP, an astrocytic protein, in injured spinal cord. The present results indicate that the mouse BMSC can migrate into the CNS lesion and differentiate into the neurons or astrocytes, and that bis-benzimide is a simple and useful marker to label the donor cells and to evaluate their migration and differentiation in the host neural tissues over a long period.
AuthorsJangBo Lee, Satoshi Kuroda, Hideo Shichinohe, Jun Ikeda, Toshitaka Seki, Kazutoshi Hida, Mitsuhiro Tada, Ken-ichi Sawada, Yoshinobu Iwasaki
JournalNeuropathology : official journal of the Japanese Society of Neuropathology (Neuropathology) Vol. 23 Issue 3 Pg. 169-80 (Sep 2003) ISSN: 0919-6544 [Print] Australia
PMID14570283 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorescent Dyes
  • Glial Fibrillary Acidic Protein
  • Microtubule-Associated Proteins
  • Bisbenzimidazole
Topics
  • Animals
  • Bisbenzimidazole (pharmacology)
  • Bone Marrow Cells (metabolism)
  • Bone Marrow Transplantation
  • Cell Differentiation
  • Cell Movement
  • Cerebral Infarction (therapy)
  • Disease Models, Animal
  • Flow Cytometry
  • Fluorescent Dyes (pharmacology)
  • Glial Fibrillary Acidic Protein (biosynthesis)
  • Graft Survival
  • Male
  • Mice
  • Microtubule-Associated Proteins (biosynthesis)
  • Neuroglia (cytology)
  • Neurons (cytology)
  • Spinal Cord Injuries (therapy)
  • Staining and Labeling
  • Stem Cell Transplantation
  • Stromal Cells (transplantation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: